Form D · Biotechnology
THERANOSTICS HEALTH, INC.
Rockville, MD · CIK 0001390534
Offering snapshot reported Sep 14, 2015 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 12, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2015 | Initial | $150,000 | No comparison | 6 | SEC filing |
| Sep 14, 2015 | Amendment | $225,000 | $0vs Sep 11, 2015 | 5 | SEC filing |
| Sep 11, 2015 | Initial | $225,000 | No comparison | 5 | SEC filing |
| Jun 29, 2015 | Amendment | $855,000 | $0vs Jun 29, 2015 | 12 | SEC filing |
| Jun 29, 2015 | Amendment | $1,490,000 | $1,190,000vs Jan 16, 2015 | 14 | SEC filing |
| Jun 29, 2015 | Amendment | $855,000 | $0vs Nov 3, 2014 | 12 | SEC filing |
| Jan 16, 2015 | Initial | $300,000 | No comparison | 3 | SEC filing |
| Nov 3, 2014 | Amendment | $855,000 | $450,000vs Sep 18, 2014 | 12 | SEC filing |
| Sep 18, 2014 | Initial | $405,000 | No comparison | 9 | SEC filing |
| Apr 15, 2014 | Initial | $200,000 | No comparison | 4 | SEC filing |
| Nov 21, 2013 | Amendment | $1,910,000 | $815,000vs Jul 30, 2013 | 25 | SEC filing |
| Jul 30, 2013 | Initial | $40,000 | No comparison | 4 | SEC filing |
| Jul 30, 2013 | Amendment | $1,095,000 | $40,000vs Jul 17, 2013 | 22 | SEC filing |
| Jul 17, 2013 | Initial | $1,055,000 | No comparison | 22 | SEC filing |
| Jun 21, 2011 | Amendment | $530,000 | $15,000vs May 20, 2011 | 7 | SEC filing |
| May 20, 2011 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| May 20, 2011 | Amendment | $515,000 | $150,000vs Apr 7, 2011 | 6 | SEC filing |
| Apr 7, 2011 | Initial | $365,000 | No comparison | 5 | SEC filing |
| Jan 25, 2011 | Initial | $583,750 | No comparison | 6 | SEC filing |
| Feb 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-247591
Source: Form D, filed Sep 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph S Bailes, Md | Director |
| James N Cooper, Md | Director, Executive |
| Mitchell P Cybulski | Director |
| Eric M Eastman, Ph D | Director |
| Luis T Gutierrez, Jr | Director, Executive |
| Glenn D Hoke, Ph D | Director, Executive |
| William D King | Director |
| Kevin G Quinn | Director |
| Barry S Strauch, Md | Director |
| Michael Dendy Young | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
15010 Broschart Road, Second Floor
Rockville, MD, 20850
Rockville, MD, 20850